 |
 |
generics
FDA denies request to block generic versions of Opana ER
May 14, 2013By Tracey Walker
FDA has denied Endo Health Solutions' petition to block generic forms of its opioid agonist Opana ER, which contains oxymorphone. FDA’s decision comes just weeks after it nixed generic OxyContin and approved abuse-deterrent labeling for reformulated OxyContin (Purdue Pharma).Supreme Court will define generic drugmakers' liability
April 19, 2013By Alexander B. Reich
Federal law does not allow generic pharma companies to deviate from brand formula.Novartis disappointed by loss of India patent case for Glivec
April 02, 2013By Formulary Staff
On April 1, the Indian Supreme Court denied Novartis’ appeal challenging the rejection of a patent for its cancer drug Glivec (imatinib mesylate), which has been patented in almost 40 countries including China, Russia, and Taiwan. This landmark ruling ends a 7-year legal battle by Novartis, which never has been granted an original patent for Glivec in India. The ruling will hinder medical progress and innovation, the manufacturer said.Unlock the right combination of generic, branded topical preparations to maximize efficacy
April 01, 2013By Ilya Petrou M.D.
Contrary to popular belief, not all generic and branded topical preparations are created equal in terms of efficacy and tolerability, in part due to the crucial differences in the vehicle used.AMCP calls on Congress for prohibition of generic exclusion agreements
March 18, 2013By Formulary Staff
The Academy of Managed Care Pharmacy (AMCP) is urging US House leaders to consider a number of proposals to rein in federal spending on healthcare without compromising the popular programs of Medicare and Medicaid.FDA approves first generic Suboxone for maintenance treatment of opioid drug dependence
February 25, 2013By From Staff Reports
FDA has approved generic buprenorphine hydrochloride (HCl) and naloxone HCl dihydrate sublingual tablets (Amneal Pharmaceuticals), the first generic generic versions of Suboxone (Reckitt Benckiser Healthcare (UK)) sublingual tablets for maintenance treatment of opioid drug dependence.New Products for Pharmacists- Rx, OTC, and generics (February 2013)
February 14, 2013
A survey of new Rx, new generic, and new OTC productsNew Products for Pharmacists: Rx and generics (January 2013)
January 14, 2013
A survey of new Rx and generic products